Signify Bioactive

Signify Bioactive - not available

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00026107

Enrollment

100

Registered

2021-08-19

Start date

2021-08-12

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M54.4

Interventions

Group 1: Data is collected from patients who have had Signify bone replacement during their lumbar back surgery.

Eligibility

Sex/Gender

All

Age

21 Years to No maximum

Inclusion criteria

Inclusion criteria: Age at least 21 years, full grown treated with Signify 6 - weeks follow-up

Exclusion criteria

Exclusion criteria: anaphylaxis, multiple allergy severe neurological or vascular disease systemic or metabolic disorder affecting wound healing active infection in the surgical area or systemic infection (including HIV or Hep-C treatment) hypercalcemia pregnancy renal failure Prisoner status

Design outcomes

Primary

Measure	Time frame
Collect available clinical safety data	—

Countries

Germany

Contacts

Public ContactAnne Wustmann

Klinikum Magdeburg gGmbH

Anne.Wustmann@Klinikum-Magdeburg.de03917917528

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026